3062 
† HR 2617 EAS2 
ing ‘‘first receives a waiver under section 303(g) of 
the Controlled Substances Act on or after January 1, 
2019’’ and inserting ‘‘first begins prescribing narcotic 
drugs in schedule III, IV, or V of section 202 of the 
Controlled Substances Act for the purpose of mainte-
nance or detoxification treatment on or after January 
1, 2021’’. 
(6) Section 1834(o)(3)(C)(ii) of the Social Secu-
rity Act (42 U.S.C. 1395m(o)(3)(C)(ii)) is amended 
by striking ‘‘first receives a waiver under section 
303(g) of the Controlled Substances Act on or after 
January 1, 2019’’ and inserting ‘‘first begins pre-
scribing narcotic drugs in schedule III, IV, or V of 
section 202 of the Controlled Substances Act for the 
purpose of maintenance or detoxification treatment 
on or after January 1, 2021’’. 
(7) Section 1866F(c)(3) of the Social Security 
Act (42 U.S.C. 1395cc–6(c)(3)) is amended— 
(A) in subparagraph (A), by adding ‘‘and’’ 
at the end; 
(B) in subparagraph (B), by striking ‘‘; 
and’’ and inserting a period; and 
(C) by striking subparagraph (C). 
(8) Section 1903(aa)(2)(C) of the Social Security 
Act (42 U.S.C. 1396b(aa)(2)(C)) is amended—
3063 
† HR 2617 EAS2 
(A) in clause (i), by adding ‘‘and’’ at the 
end; 
(B) by striking clause (ii); and 
(C) by redesignating clause (iii) as clause 
(ii). 
SEC. 1263. REQUIRING PRESCRIBERS OF CONTROLLED SUB-
STANCES TO COMPLETE TRAINING. 
(a) IN GENERAL.—Section 303 of the Controlled Sub-
stances Act (21 U.S.C. 823) is amended by adding at the 
end the following: 
‘‘(l) REQUIRED TRAINING FOR PRESCRIBERS.— 
‘‘(1) TRAINING REQUIRED.—As a condition on 
registration under this section to dispense controlled 
substances in schedule II, III, IV, or V, the Attorney 
General shall require any qualified practitioner, be-
ginning with the first applicable registration for the 
practitioner, to meet the following: 
‘‘(A) If the practitioner is a physician (as 
defined under section 1861(r) of the Social Secu-
rity Act) and the practitioner meets one or more 
of the following conditions: 
‘‘(i) The physician holds a board cer-
tification in addiction psychiatry or addic-
tion medicine from the American Board of 
Medical Specialties.
3064 
† HR 2617 EAS2 
‘‘(ii) The physician holds a board cer-
tification from the American Board of Ad-
diction Medicine. 
‘‘(iii) The physician holds a board cer-
tification in addiction medicine from the 
American Osteopathic Association. 
‘‘(iv) The physician has, with respect 
to the treatment and management of pa-
tients with opioid or other substance use 
disorders, or the safe pharmacological man-
agement of dental pain and screening, brief 
intervention, and referral for appropriate 
treatment of patients with or at risk of de-
veloping opioid or other substance use dis-
orders, completed not less than 8 hours of 
training (through classroom situations, sem-
inars at professional society meetings, elec-
tronic communications, or otherwise) that is 
provided by— 
‘‘(I) the American Society of Ad-
diction Medicine, the American Acad-
emy of Addiction Psychiatry, the 
American Medical Association, the 
American Osteopathic Association, the 
American 
Dental 
Association, 
the
3065 
† HR 2617 EAS2 
American Association of Oral and 
Maxillofacial Surgeons, the American 
Psychiatric Association, or any other 
organization accredited by the Accredi-
tation Council for Continuing Medical 
Education (ACCME) or the Commis-
sion for Continuing Education Pro-
vider Recognition (CCEPR); 
‘‘(II) any organization accredited 
by a State medical society accreditor 
that is recognized by the ACCME or 
the CCEPR; 
‘‘(III) any organization accredited 
by the American Osteopathic Associa-
tion to provide continuing medical 
education; or 
‘‘(IV) any organization approved 
by the Assistant Secretary for Mental 
Health 
and 
Substance 
Use, 
the 
ACCME, or the CCEPR. 
‘‘(v) The physician graduated in good 
standing from an accredited school of 
allopathic medicine, osteopathic medicine, 
dental surgery, or dental medicine in the 
United States during the 5-year period im-
3066 
† HR 2617 EAS2 
mediately preceding the date on which the 
physician first registers or renews under 
this section and has successfully completed a 
comprehensive allopathic or osteopathic 
medicine curriculum or accredited medical 
residency or dental surgery or dental medi-
cine curriculum that included not less than 
8 hours of training on— 
‘‘(I) treating and managing pa-
tients with opioid or other substance 
use disorders, including the appro-
priate clinical use of all drugs ap-
proved by the Food and Drug Admin-
istration for the treatment of a sub-
stance use disorder; or 
‘‘(II) the safe pharmacological 
management 
of 
dental 
pain 
and 
screening, brief intervention, and refer-
ral for appropriate treatment of pa-
tients with or at risk of developing 
opioid and other substance use dis-
orders. 
‘‘(B) If the practitioner is not a physician 
(as defined under section 1861(r) of the Social 
Security Act), the practitioner is legally author-
3067 
† HR 2617 EAS2 
ized by the State to dispense controlled sub-
stances under schedule II, III, IV, or V and is 
dispensing such substances within such State in 
accordance with all applicable State laws, and 
the practitioner meets one or more of the fol-
lowing conditions: 
‘‘(i) The practitioner has completed not 
fewer than 8 hours of training with respect 
to the treatment and management of pa-
tients with opioid or other substance use 
disorders (through classroom situations, 
seminars at professional society meetings, 
electronic communications, or otherwise) 
provided by the American Society of Addic-
tion Medicine, the American Academy of 
Addiction Psychiatry, the American Med-
ical Association, the American Osteopathic 
Association, 
the 
American 
Nurses 
Credentialing Center, the American Psy-
chiatric Association, the American Associa-
tion of Nurse Practitioners, the American 
Academy of Physician Associates, or any 
other organization approved or accredited 
by the Assistant Secretary for Mental 
Health and Substance Use or the Accredita-
3068 
† HR 2617 EAS2 
tion Council for Continuing Medical Edu-
cation. 
‘‘(ii) The practitioner has graduated in 
good standing from an accredited physician 
assistant school or accredited school of ad-
vanced practice nursing in the United 
States during the 5-year period imme-
diately preceding the date on which the 
practitioner first registers or renews under 
this section and has successfully completed a 
comprehensive physician assistant or ad-
vanced practice nursing curriculum that in-
cluded not fewer than 8 hours of training 
on treating and managing patients with 
opioid and other substance use disorders, 
including the appropriate clinical use of all 
drugs approved by the Food and Drug Ad-
ministration for the treatment of a sub-
stance use disorder. 
‘‘(2) ONE-TIME TRAINING.— 
‘‘(A) IN GENERAL.—The Attorney General 
shall not require any qualified practitioner to 
complete the training described in clause (iv) or 
(v) of paragraph (1)(A) or clause (i) or (ii) of 
paragraph (1)(B) more than once.
3069 
† HR 2617 EAS2 
‘‘(B) NOTIFICATION.—Not later than 90 
days after the date of the enactment of the Re-
storing Hope for Mental Health and Well-Being 
Act of 2022, the Attorney General shall provide 
to qualified practitioners a single written, elec-
tronic notification of the training described in 
clauses (iv) and (v) of paragraph (1)(A) or 
clauses (i) and (ii) of paragraph (1)(B). 
‘‘(3) RULE OF CONSTRUCTION.—Nothing in this 
subsection shall be construed— 
‘‘(A) to preclude the use, by a qualified 
practitioner, of training received pursuant to 
this subsection to satisfy registration require-
ments of a State or for some other lawful pur-
pose; or 
‘‘(B) to preempt any additional require-
ments by a State related to the dispensing of 
controlled substances under schedule II, III, IV, 
or V. 
‘‘(4) DEFINITIONS.—In this section: 
‘‘(A) FIRST APPLICABLE REGISTRATION.— 
The term ‘first applicable registration’ means the 
first registration or renewal of registration by a 
qualified practitioner under this section that oc-
curs on or after the date that is 180 days after
3070 
† HR 2617 EAS2 
the date of enactment of the Restoring Hope for 
Mental Health and Well-Being Act of 2022. 
‘‘(B) QUALIFIED
PRACTITIONER.—In this 
subsection, the term ‘qualified practitioner’ 
means a practitioner who— 
‘‘(i) is licensed under State law to pre-
scribe controlled substances; and 
‘‘(ii) is not solely a veterinarian.’’. 
(b) REPORT.—Not later than 5 years after the date 
of enactment of this Act, the Secretary, in consultation with 
the Attorney General, shall submit to the Committee on 
Health, Education, Labor, and Pensions of the Senate and 
the Committee on Energy and Commerce of the House of 
Representatives a report assessing the impact of the elimi-
nation of the waiver program established under section 
303(g)(2) of the Controlled Substances Act (21 U.S.C. 
823(g)(2)), as amended by the Drug Addiction Treatment 
Act of 2000. 
SEC. 1264. INCREASE IN NUMBER OF DAYS BEFORE WHICH 
CERTAIN CONTROLLED SUBSTANCES MUST 
BE ADMINISTERED. 
Section 309A(a)(5) of the Controlled Substances Act 
(21 U.S.C. 829a(a)(5)) is amended by striking ‘‘14 days’’ 
and inserting ‘‘45 days’’.
3071 
† HR 2617 EAS2 
CHAPTER 7—OPIOID CRISIS RESPONSE 
SEC. 1271. OPIOID PRESCRIPTION VERIFICATION. 
(a) MATERIALS FOR TRAINING PHARMACISTS ON CER-
TAIN CIRCUMSTANCES UNDER WHICH A PHARMACIST MAY 
DECLINE TO FILL A PRESCRIPTION.— 
(1) UPDATES TO MATERIALS.—Section 3212(a) 
of the SUPPORT for Patients and Communities Act 
(21 U.S.C. 829 note) is amended by striking ‘‘Not 
later than 1 year after the date of enactment of this 
Act, the Secretary of Health and Human Services, in 
consultation with the Administrator of the Drug En-
forcement Administration, Commissioner of Food and 
Drugs, Director of the Centers for Disease Control 
and Prevention, and Assistant Secretary for Mental 
Health and Substance Use, shall develop and dissemi-
nate’’ and inserting ‘‘The Secretary of Health and 
Human Services, in consultation with the Adminis-
trator of the Drug Enforcement Administration, Com-
missioner of Food and Drugs, Director of the Centers 
for Disease Control and Prevention, and Assistant 
Secretary for Mental Health and Substance Use, shall 
develop and disseminate not later than 1 year after 
the date of enactment of the Restoring Hope for Men-
tal Health and Well-Being Act of 2022, and update 
periodically thereafter’’.
3072 
† HR 2617 EAS2 
(2) MATERIALS INCLUDED.—Section 3212(b) of 
the SUPPORT for Patients and Communities Act (21 
U.S.C. 829 note) is amended— 
(A) by redesignating paragraphs (1) and 
(2) as paragraphs (2) and (3), respectively; and 
(B) by inserting before paragraph (2), as so 
redesignated, the following new paragraph: 
‘‘(1) pharmacists on how to verify the identity of 
the patient;’’. 
(3) MATERIALS
FOR
TRAINING
ON
PATIENT 
VERIFICATION .—Section 3212 of the SUPPORT for 
Patients and Communities Act (21 U.S.C. 829 note) 
is amended by adding at the end the following new 
subsection: 
‘‘(d) MATERIALS FOR TRAINING ON VERIFICATION OF 
IDENTITY.—Not later than 1 year after the date of enact-
ment of this subsection, the Secretary of Health and Human 
Services, after seeking stakeholder input in accordance with 
subsection (c), shall— 
‘‘(1) update the materials developed under sub-
section (a) to include information for pharmacists on 
how to verify the identity of the patient; and 
‘‘(2) disseminate, as appropriate, the updated 
materials.’’.
3073 
† HR 2617 EAS2 
(b) INCENTIVIZING STATES TO BUILD OR MAINTAIN 
PRESCRIPTION DRUG MONITORING PROGRAMS.— 
(1) IN GENERAL.—Section 392A of the Public 
Health Service Act (42 U.S.C. 280b–1) is amended— 
(A) by redesignating subsections (c) and (d) 
as subsections (d) and (e), respectively; and 
(B) by inserting after subsection (b) the fol-
lowing new subsection: 
‘‘(c) PRIORITY.—In awarding grants to States under 
subsections (a) and (b), the Director of the Centers for Dis-
ease Control and Prevention may give priority to jurisdic-
tions with a disproportionately high rate of drug overdoses 
or drug overdose deaths, as applicable.’’. 
(2) CONFORMING CHANGE.—Section 392A of the 
Public Health Service Act (42 U.S.C. 280b–1) is 
amended by striking ‘‘Indian tribes’’ each place it ap-
pears and inserting ‘‘Indian Tribes’’. 
SEC. 1272. SYNTHETIC OPIOID AND EMERGING DRUG MIS-
USE DANGER AWARENESS. 
(a) IN GENERAL.—Not later than one year after the 
date of enactment of this Act, the Secretary shall provide 
for the planning and implementation of a public education 
campaign to raise public awareness of synthetic opioids (in-
cluding fentanyl and its analogues) and emerging drug use 
and misuse issues, as appropriate. Such campaign related
3074 
† HR 2617 EAS2 
to synthetic opioids shall include the dissemination of infor-
mation that— 
(1) promotes awareness about the potency and 
dangers of fentanyl and its analogues and other syn-
thetic opioids; 
(2) explains services provided by the Substance 
Abuse and Mental Health Services Administration 
and the Centers for Disease Control and Prevention 
(and any entity providing such services under a con-
tract entered into with such agencies) with respect to 
the use and misuse of opioids (including synthetic 
opioids) and other emerging drug threats, such as 
stimulants, as appropriate; and 
(3) relates generally to opioid use and pain 
management, including information on alternative, 
nonopioid pain management treatments. 
The Secretary shall update such campaign to address 
emerging drug misuse issues, as appropriate. 
(b) USE OF MEDIA.—The campaign under subsection 
(a) may be implemented through the use of television, radio, 
internet, in-person public communications, and other com-
mercial marketing venues and may be targeted to specific 
demographic groups. 
(c) CONSIDERATION OF REPORT FINDINGS.—In plan-
ning and implementing the public education campaign
3075 
† HR 2617 EAS2 
under subsection (a) related to synthetic opioids, the Sec-
retary shall take into consideration the findings of the re-
port required under section 7001 of the SUPPORT for Pa-
tients and Communities Act (Public Law 115–271). 
(d) CONSULTATION.—In coordinating the campaign 
under subsection (a), the Secretary shall consult with the 
Assistant Secretary for Mental Health and Substance Use 
to provide ongoing advice on the effectiveness of information 
disseminated through the campaign. 
(e) REQUIREMENT OF CAMPAIGN.—The campaign im-
plemented under subsection (a) shall not be duplicative of 
any other Federal efforts relating to eliminating substance 
use and misuse. 
(f) EVALUATION.— 
(1) IN
GENERAL.—The Secretary shall ensure 
that the campaign implemented under subsection (a) 
is subject to an independent evaluation, beginning 2 
years after the date of enactment of this Act, and 2 
years thereafter. 
(2) MEASURES
AND
BENCHMARKS.—For pur-
poses of an evaluation conducted pursuant to para-
graph (1), the Secretary shall— 
(A) establish baseline measures and bench-
marks to quantitatively evaluate the impact of 
the campaign under this section; and
3076 
† HR 2617 EAS2 
(B) conduct qualitative assessments regard-
ing the effectiveness of strategies employed under 
this section. 
(g) REPORT.—The Secretary shall, beginning 2 years 
after the date of enactment of this Act, and 2 years there-
after, submit to Congress a report on the effectiveness of the 
campaign implemented under subsection (a) towards meet-
ing the measures and benchmarks established under sub-
section (f)(2). 
(h) DISSEMINATION OF INFORMATION THROUGH PRO-
VIDERS.—The Secretary shall develop and implement a 
plan for the dissemination of information related to syn-
thetic opioids, to health care providers who participate in 
Federal programs, including programs administered by the 
Department of Health and Human Services, the Indian 
Health Service, the Department of Veterans Affairs, the De-
partment of Defense, and the Health Resources and Services 
Administration, the Medicare program under title XVIII 
of the Social Security Act (42 U.S.C. 1395 et seq.), and 
the Medicaid program under title XIX of such Act (42 
U.S.C. 1396 et seq.). 
(i) TRAINING GUIDE AND OUTREACH ON SYNTHETIC 
OPIOID EXPOSURE PREVENTION.— 
(1) TRAINING GUIDE.—Not later than 18 months 
after the date of enactment of this Act, the Secretary
3077 
† HR 2617 EAS2 
shall design, publish, and make publicly available on 
the internet website of the Department of Health and 
Human Services, a training guide and webinar for 
first responders and other individuals who also may 
be at high risk of exposure to synthetic opioids that 
details measures to prevent that exposure. 
(2) OUTREACH.—Not later than 18 months after 
the date of enactment of this Act, the Secretary shall 
also conduct outreach about the availability of the 
training guide and webinar published under para-
graph (1) to— 
(A) fire department staff; 
(B) law enforcement officers; 
(C) ambulance transport and other first re-
sponders; 
(D) hospital emergency department per-
sonnel; and 
(E) other high-risk occupations, as identi-
fied by the Secretary. 
SEC. 1273. GRANT PROGRAM FOR STATE AND TRIBAL RE-
SPONSE TO OPIOID USE DISORDERS. 
Section 1003 of the 21st Century Cures Act (42 U.S.C. 
290ee–3 note) is amended to read as follows:
3078 
† HR 2617 EAS2 
‘‘SEC. 1003. GRANT PROGRAM FOR STATE AND TRIBAL RE-
SPONSE TO OPIOID USE DISORDERS. 
‘‘(a) IN GENERAL.—The Secretary of Health and 
Human Services (referred to in this section as the ‘Sec-
retary’) shall carry out the grant program described in sub-
section (b) for purposes of addressing opioid misuse and 
use disorders and, as applicable and appropriate, stimulant 
misuse and use disorders, within States, Indian Tribes, and 
populations served by Tribal organizations and Urban In-
dian organizations. 
‘‘(b) GRANTS PROGRAM.— 
‘‘(1) IN GENERAL.—Subject to the availability of 
appropriations, the Secretary shall award grants to 
the single State agency responsible for administering 
the substance use prevention, treatment, and recovery 
services block grant under subpart II of part B of title 
XIX of the Public Health Service Act (42 U.S.C. 
300x–21 et seq.), Indian Tribes, and Tribal organiza-
tions for the purpose of addressing opioid misuse and 
use disorders, and as applicable and appropriate, 
stimulant misuse and use disorders, within such 
States, such Indian Tribes, and populations served by 
such Tribal organizations, in accordance with para-
graph (2). Indian Tribes or Tribal organizations may 
also apply for an award as part of a consortia or
3079 
† HR 2617 EAS2 
may include in an application a partnership with an 
Urban Indian organization. 
‘‘(2) MINIMUM ALLOCATIONS.—Notwithstanding 
subsection (i)(3), in determining grant amounts for 
each recipient of a grant under paragraph (1), the 
Secretary shall ensure that each State and the Dis-
trict of Columbia receive not less than $4,000,000 and 
ensure that each Territory receives not less than 
$250,000. 
‘‘(3) FORMULA METHODOLOGY.— 
‘‘(A) IN GENERAL.—At least 30 days before 
publishing a funding opportunity announcement 
with respect to grants under this section, the Sec-
retary shall— 
‘‘(i) develop a formula methodology to 
be followed in allocating grant funds 
awarded under this section among grantees, 
which, where applicable and appropriate 
based on populations being served by the 
relevant entity— 
‘‘(I) with respect to allocations for 
States, gives preference to States whose 
populations have a prevalence of 
opioid misuse and use disorders or 
drug overdose deaths that is substan-
3080 
† HR 2617 EAS2 
tially higher relative to the populations 
of other States; 
‘‘(II) with respect to allocations 
for Tribes and Tribal organizations, 
gives preferences to Tribes and Tribal 
organizations (including those apply-
ing in partnership with an Urban In-
dian organization) serving populations 
with demonstrated need with respect to 
opioid misuse and use disorders or 
drug overdose deaths; 
‘‘(III) includes performance as-
sessments for continuation awards; and 
‘‘(IV) ensures that the formula 
avoids a funding cliff between States 
with similar overdose mortality rates 
to prevent funding reductions when 
compared to prior year allocations, as 
determined by the Secretary; and 
‘‘(ii) not later than 30 days after de-
veloping the formula methodology under 
clause (i), submit the formula methodology 
to— 
‘‘(I) the Committee on Health, 
Education, Labor, and Pensions and
3081 
† HR 2617 EAS2 
the Committee on Appropriations of 
the Senate; and 
‘‘(II) the Committee on Energy 
and Commerce and the Committee on 
Appropriations of the House of Rep-
resentatives. 
‘‘(B) REPORT.—Not later than two years 
after the date of the enactment of the Restoring 
Hope for Mental Health and Well-Being Act of 
2022, the Comptroller General of the United 
States shall submit to the Committee on Health, 
Education, Labor, and Pensions of the Senate 
and the Committee on Energy and Commerce of 
the House of Representatives a report that— 
‘‘(i) assesses how grant funding is allo-
cated to States under this section and how 
such allocations have changed over time; 
‘‘(ii) assesses how any changes in fund-
ing under this section have affected the ef-
forts of States to address opioid misuse and 
use disorders and, as applicable and appro-
priate, stimulant misuse and use disorders; 
and 
‘‘(iii) assesses the use of funding pro-
vided through the grant program under this
3082 
† HR 2617 EAS2 
section and other similar grant programs 
administered by the Substance Abuse and 
Mental Health Services Administration. 
‘‘(4) USE
OF
FUNDS.—Grants awarded under 
this subsection shall be used for carrying out activi-
ties that supplement activities pertaining to opioid 
misuse and use disorders and, as applicable and ap-
propriate, stimulant misuse and use disorders (in-
cluding co-occurring substance misuse and use dis-
orders), undertaken by the entities described in para-
graph (1), which may include public health-related 
activities such as the following: 
‘‘(A) Implementing substance use disorder 
and overdose prevention activities, including pri-
mary prevention activities, and evaluating such 
activities to identify effective strategies to pre-
vent substance use disorders and overdoses, which 
may include drugs or devices approved, cleared, 
or otherwise legally marketed under the Federal 
Food, Drug, and Cosmetic Act. 
‘‘(B) Establishing or improving prescrip-
tion drug monitoring programs. 
‘‘(C) Training for health care practitioners, 
such as best practices for prescribing opioids, 
pain management, recognizing potential cases of
3083 
† HR 2617 EAS2 
substance use disorders, referral of patients to 
treatment programs, preventing diversion of con-
trolled substances, and overdose prevention. 
‘‘(D) Supporting access to and the provision 
of substance use disorder-related health care serv-
ices, including— 
‘‘(i) services provided by federally cer-
tified opioid treatment programs; 
‘‘(ii) services provided in outpatient 
and residential substance use disorder treat-
ment programs or facilities, including those 
that utilize medication-assisted treatment, 
as appropriate; or 
‘‘(iii) services provided by other appro-
priate health care providers to treat sub-
stance use disorders, including crisis serv-
ices and services provided in integrated 
health care settings by appropriate health 
care providers that treat substance use dis-
orders. 
‘‘(E) Recovery support services, including— 
‘‘(i) community-based services that in-
clude education, outreach, and peer sup-
ports such as peer support specialists and 
recovery coaches to help support recovery;
3084 
† HR 2617 EAS2 
‘‘(ii) mutual aid recovery programs 
that support medication-assisted treatment; 
‘‘(iii) services to address housing needs; 
or 
‘‘(iv) services related to supporting 
families that include an individual with a 
substance use disorder. 
‘‘(F) Other public health-related activities, 
as such entity determines appropriate, related to 
addressing opioid misuse and use disorders and, 
as applicable and appropriate, stimulant misuse 
and use disorders, within such entity, including 
directing resources in accordance with local 
needs related to substance use disorders. 
‘‘(c) ACCOUNTABILITY AND OVERSIGHT.—A State re-
ceiving a grant under subsection (b) shall submit to the Sec-
retary a description of— 
‘‘(1) the purposes for which the grant funds re-
ceived by the State under such subsection for the pre-
ceding fiscal year were expended and a description of 
the activities of the State under the grant; 
‘‘(2) the ultimate recipients of amounts provided 
to the State; 
‘‘(3) the number of individuals served through 
the grant; and
3085 
† HR 2617 EAS2 
‘‘(4) such other information as determined ap-
propriate by the Secretary. 
‘‘(d) LIMITATIONS.—Any funds made available pursu-
ant to subsection (i) shall not be used for any purpose other 
than the grant program under subsection (b). 
‘‘(e) INDIAN TRIBES AND TRIBAL ORGANIZATIONS.— 
The Secretary, in consultation with Indian Tribes and 
Tribal organizations, shall identify and establish appro-
priate mechanisms for Indian Tribes and Tribal organiza-
tions to demonstrate or report the information as required 
under subsections (b), (c), and (d). 
‘‘(f) REPORT
TO CONGRESS.—Not later than Sep-
tember 30, 2024, and biennially thereafter, the Secretary 
shall submit to the Committee on Health, Education, Labor, 
and Pensions of the Senate and the Committee on Energy 
and Commerce of the House of Representatives, and the 
Committees on Appropriations of the House of Representa-
tives and the Senate, a report that includes a summary of 
the information provided to the Secretary in reports made 
pursuant to subsections (c) and (d), including— 
‘‘(1) the purposes for which grant funds are 
awarded under this section; 
‘‘(2) the activities of the grant recipients; and
3086 
† HR 2617 EAS2 
‘‘(3) each entity that receives a grant under this 
section, including the funding level provided to such 
recipient. 
‘‘(g) TECHNICAL ASSISTANCE.—The Secretary, includ-
ing through the Tribal Training and Technical Assistance 
Center of the Substance Abuse and Mental Health Services 
Administration, as applicable, shall provide entities de-
scribed in subsection (b)(1) with technical assistance con-
cerning grant application and submission procedures under 
this section, award management activities, and enhancing 
outreach and direct support to rural and underserved com-
munities and providers in addressing substance use dis-
orders. 
‘‘(h) DEFINITIONS.—In this section: 
‘‘(1) INDIAN TRIBE.—The term ‘Indian Tribe’ 
has the meaning given the term ‘Indian tribe’ in sec-
tion 4 of the Indian Self-Determination and Edu-
cation Assistance Act (25 U.S.C. 5304). 
‘‘(2) TRIBAL ORGANIZATION.—The term ‘Tribal 
organization’ has the meaning given the term ‘tribal 
organization’ in section 4 of the Indian Self-Deter-
mination and Education Assistance Act (25 U.S.C. 
5304).
3087 
† HR 2617 EAS2 
‘‘(3) STATE.—The term ‘State’ has the meaning 
given such term in section 1954(b) of the Public 
Health Service Act (42 U.S.C. 300x–64(b)). 
‘‘(4) URBAN INDIAN ORGANIZATION.—The term 
‘Urban Indian organization’ has the meaning given 
such term in section 4 of the Indian Health Care Im-
provement Act. 
‘‘(i) AUTHORIZATION OF APPROPRIATIONS.— 
‘‘(1) IN GENERAL.—For purposes of carrying out 
the grant program under subsection (b), there is au-
thorized to be appropriated $1,750,000,000 for each of 
fiscal years 2023 through 2027. 
‘‘(2) FEDERAL ADMINISTRATIVE EXPENSES.—Of 
the amounts made available for each fiscal year to 
award grants under subsection (b), the Secretary shall 
not use more than 2 percent for Federal administra-
tive expenses, training, technical assistance, and eval-
uation. 
‘‘(3) SET ASIDE.—Of the amounts made avail-
able for each fiscal year to award grants under sub-
section (b) for a fiscal year, the Secretary shall— 
‘‘(A) award not more than 5 percent to In-
dian Tribes and Tribal organizations; and 
‘‘(B) of the amount remaining after appli-
cation of subparagraph (A), set aside up to 15
3088 
† HR 2617 EAS2 
percent for awards to States with the highest 
age-adjusted rate of drug overdose death based on 
the ordinal ranking of States according to the 
Director of the Centers for Disease Control and 
Prevention.’’. 
Subtitle C—Access to Mental Health 
Care and Coverage 
CHAPTER 1—IMPROVING UPTAKE AND PA-
TIENT ACCESS TO INTEGRATED CARE 
SERVICES 
SEC. 1301. IMPROVING UPTAKE AND PATIENT ACCESS TO 
INTEGRATED CARE SERVICES. 
Section 520K of the Public Health Service Act (42 
U.S.C. 290bb–42) is amended to read as follows: 
‘‘SEC. 520K. IMPROVING UPTAKE AND PATIENT ACCESS TO 
INTEGRATED CARE SERVICES. 
‘‘(a) DEFINITIONS.—In this section: 
‘‘(1) ELIGIBLE ENTITY.—The term ‘eligible enti-
ty’ means a State, or an appropriate State agency, 
in collaboration with— 
‘‘(A) 1 or more qualified community pro-
grams as described in section 1913(b)(1); or 
‘‘(B) 1 or more health centers (as defined in 
section 330(a)), rural health clinics (as defined 
in section 1861(aa) of the Social Security Act),
3089 
† HR 2617 EAS2 
or Federally qualified health centers (as defined 
in such section), or primary care practices serv-
ing adult or pediatric patients or both. 
‘‘(2) INTEGRATED CARE; BIDIRECTIONAL INTE-
GRATED CARE.— 
‘‘(A) The term ‘integrated care’ means col-
laborative models, including the psychiatric col-
laborative care model and other evidence-based or 
evidence-informed models, or practices for coordi-
nating and jointly delivering behavioral and 
physical health services, which may include 
practices that share the same space in the same 
facility. 
‘‘(B) The term ‘bidirectional integrated 
care’ means the integration of behavioral health 
care and specialty physical health care, and the 
integration of primary and physical health care 
within specialty behavioral health settings, in-
cluding within primary health care settings. 
‘‘(3) 
PSYCHIATRIC
COLLABORATIVE
CARE 
MODEL.—The term ‘psychiatric collaborative care 
model’ means the evidence-based, integrated behav-
ioral health service delivery method that includes— 
‘‘(A) care directed by the primary care 
team;
3090 
† HR 2617 EAS2 
‘‘(B) structured care management; 
‘‘(C) regular assessments of clinical status 
using developmentally appropriate, validated 
tools; and 
‘‘(D) modification of treatment as appro-
priate. 
‘‘(4) SPECIAL POPULATION.—The term ‘special 
population’ means— 
‘‘(A) adults with a serious mental illness or 
adults who have co-occurring mental illness and 
physical health conditions or chronic disease; 
‘‘(B) children and adolescents with a serious 
emotional disturbance who have a co-occurring 
physical health condition or chronic disease; 
‘‘(C) individuals with a substance use dis-
order; or 
‘‘(D) individuals with a mental illness who 
have a co-occurring substance use disorder. 
‘‘(b) GRANTS AND COOPERATIVE AGREEMENTS.— 
‘‘(1) IN GENERAL.—The Secretary may award 
grants and cooperative agreements to eligible entities 
to support the improvement of integrated care for 
physical and behavioral health care in accordance 
with paragraph (2).
3091 
† HR 2617 EAS2 
‘‘(2) USE OF FUNDS.—A grant or cooperative 
agreement awarded under this section shall be used— 
‘‘(A) to promote full integration and col-
laboration in clinical practices between physical 
and behavioral health care, including for special 
populations; 
‘‘(B) to support the improvement of inte-
grated care models for physical and behavioral 
health care to improve overall wellness and phys-
ical health status, including for special popu-
lations; 
‘‘(C) to promote the implementation and 
improvement of bidirectional integrated care 
services provided at entities described in sub-
section (a)(1), including evidence-based or evi-
dence-informed screening, assessment, diagnosis, 
prevention, treatment, and recovery services for 
mental and substance use disorders, and co-oc-
curring physical health conditions and chronic 
diseases; and 
‘‘(D) in the case of an eligible entity that is 
collaborating with a primary care practice, to 
support the implementation of evidence-based or 
evidence-informed integrated care models, includ-
3092 
† HR 2617 EAS2 
ing the psychiatric collaborative care model, in-
cluding— 
‘‘(i) by hiring staff; 
‘‘(ii) by identifying and formalizing 
contractual relationships with other health 
care providers or other relevant entities of-
fering care management and behavioral 
health consultation to facilitate the adoption 
of integrated care, including, as applicable, 
providers who will function as psychiatric 
consultants and behavioral health care man-
agers in providing behavioral health inte-
gration services through the collaborative 
care model; 
‘‘(iii) by purchasing or upgrading soft-
ware and other resources, as applicable, 
needed to appropriately provide behavioral 
health integration, including resources need-
ed to establish a patient registry and imple-
ment measurement-based care; and 
‘‘(iv) for such other purposes as the 
Secretary determines to be applicable and 
appropriate. 
‘‘(c) APPLICATIONS.—
3093 
† HR 2617 EAS2 
‘‘(1) IN
GENERAL.—An eligible entity that is 
seeking a grant or cooperative agreement under this 
section shall submit an application to the Secretary 
at such time, in such manner, and accompanied by 
such information as the Secretary may require, in-
cluding the contents described in paragraph (2). 
‘‘(2) CONTENTS FOR AWARDS.—Any such appli-
cation of an eligible entity seeking a grant or cooper-
ative agreement under this section shall include, as 
applicable— 
‘‘(A) a description of a plan to achieve fully 
collaborative agreements to provide bidirectional 
integrated care to special populations; 
‘‘(B) a summary of the policies, if any, that 
are barriers to the provision of integrated care, 
and the specific steps, if applicable, that will be 
taken to address such barriers; 
‘‘(C) a description of partnerships or other 
arrangements with local health care providers to 
provide services to special populations and, as 
applicable, in areas with demonstrated need, 
such as Tribal, rural, or other medically under-
served communities, such as those with a work-
force shortage of mental health and substance use
3094 
† HR 2617 EAS2 
disorder, pediatric mental health, or other re-
lated professionals; 
‘‘(D) an agreement and plan to report to 
the Secretary performance measures necessary to 
evaluate patient outcomes and facilitate evalua-
tions across participating projects; and 
‘‘(E) a description of the plan or progress 
in implementing the psychiatric collaborative 
care model, as applicable and appropriate; 
‘‘(F) a description of the plan or progress of 
evidence-based or evidence-informed integrated 
care models other than the psychiatric collabo-
rative care model implemented by primary care 
practices, as applicable and appropriate; and 
‘‘(G) a plan for sustainability beyond the 
grant or cooperative agreement period under sub-
section (e). 
‘‘(d) 
GRANT
AND
COOPERATIVE
AGREEMENT 
AMOUNTS.— 
‘‘(1) TARGET AMOUNT.—The target amount that 
an eligible entity may receive for a year through a 
grant or cooperative agreement under this section 
shall be no more than $2,000,000. 
‘‘(2) ADJUSTMENT PERMITTED.—The Secretary, 
taking into consideration the quality of an eligible en-
3095 
† HR 2617 EAS2 
tity’s application and the number of eligible entities 
that received grants under this section prior to the 
date of enactment of the Restoring Hope for Mental 
Health and Well-Being Act of 2022, may adjust the 
target amount that an eligible entity may receive for 
a year through a grant or cooperative agreement 
under this section. 
‘‘(3) LIMITATION.—An eligible entity that is re-
ceiving funding under subsection (b)— 
‘‘(A) may not allocate more than 10 percent 
of the funds awarded to such eligible entity 
under this section to administrative functions; 
and 
‘‘(B) shall allocate the remainder of such 
funding to health facilities that provide inte-
grated care. 
‘‘(e) DURATION.—A grant or cooperative agreement 
under this section shall be for a period not to exceed 5 years. 
‘‘(f) REPORT ON PROGRAM OUTCOMES.—An eligible 
entity receiving a grant or cooperative agreement under this 
section shall submit an annual report to the Secretary. 
Such annual report shall include— 
‘‘(1) the progress made to reduce barriers to inte-
grated care as described in the entity’s application 
under subsection (c);
3096 
† HR 2617 EAS2 
‘‘(2) a description of outcomes with respect to 
each special population listed in subsection (a)(4), in-
cluding outcomes related to education, employment, 
and housing, or, as applicable and appropriate, out-
comes for such populations receiving behavioral health 
care through the psychiatric collaborative care model 
in primary care practices; and 
‘‘(3) progress in meeting performance metrics 
and other relevant benchmarks; and 
‘‘(4) such other information that the Secretary 
may require. 
‘‘(g) TECHNICAL ASSISTANCE FOR PRIMARY-BEHAV-
IORAL HEALTH CARE INTEGRATION.— 
‘‘(1) CERTAIN RECIPIENTS.—The Secretary may 
provide appropriate information, training, and tech-
nical assistance to eligible entities that receive a 
grant or cooperative agreement under subsection 
(b)(2), in order to help such entities meet the require-
ments of this section, including assistance with— 
‘‘(A) development and selection of integrated 
care models; 
‘‘(B) dissemination of evidence-based inter-
ventions in integrated care;
3097 
† HR 2617 EAS2 
‘‘(C) establishment of organizational prac-
tices to support operational and administrative 
success; and 
‘‘(D) as appropriate, appropriate informa-
tion, training, and technical assistance in imple-
menting the psychiatric collaborative care model 
when an eligible entity is collaborating with 1 or 
more primary care practices for the purposes of 
implementing the psychiatric collaborative care 
model. 
‘‘(2) ADDITIONAL DISSEMINATION OF TECHNICAL 
INFORMATION.—In addition to providing the assist-
ance described in paragraph (1) to recipients of a 
grant or cooperative agreement under this section, the 
Secretary may also provide such assistance to other 
States and political subdivisions of States, Indian 
Tribes and Tribal organizations, as those terms are 
defined in section 4 of the Indian Self-Determination 
and Education Assistance Act, outpatient mental 
health and addiction treatment centers, community 
mental health centers that meet the criteria under sec-
tion 1913(c), certified community behavioral health 
clinics described in section 223 of the Protecting Ac-
cess to Medicare Act of 2014, primary care organiza-
tions such as Federally qualified health centers or
3098 
† HR 2617 EAS2 
rural health clinics as defined in section 1861(aa) of 
the Social Security Act, primary health care prac-
tices, the community-based organizations, and other 
entities engaging in integrated care activities, as the 
Secretary determines appropriate. 
‘‘(h) REPORT
TO CONGRESS.—Not later than 18 
months after the date of enactment of the Restoring Hope 
for Mental Health and Well-Being Act of 2022, and annu-
ally thereafter, the Secretary shall submit a report to the 
Committee on Health, Education, Labor, and Pensions of 
the Senate and the Committee on Energy and Commerce 
of the House of Representatives summarizing the informa-
tion submitted in reports to the Secretary under subsection 
(f), including progress made in meeting performance 
metrics and the uptake of integrated care models, any ad-
justments made to target amounts pursuant to subsection 
(d)(2), and any other relevant information. 
‘‘(i) FUNDING.— 
‘‘(1) AUTHORIZATION OF APPROPRIATIONS.—To 
carry out this section, there is authorized to be appro-
priated $60,000,000 for each of fiscal years 2023 
through 2027. 
‘‘(2) INCREASING UPTAKE OF THE PSYCHIATRIC 
COLLABORATIVE
CARE
MODEL
BY
PRIMARY
CARE 
PRACTICES.—Not less than 10 percent of funds appro-
3099 
† HR 2617 EAS2 
priated to carry out this section shall be for the pur-
poses of implementing the psychiatric collaborative 
care model implemented by primary care practices 
under subsection (b). 
‘‘(3) FUNDING
CONTINGENCY.—Paragraph (2) 
shall not apply to a fiscal year unless the amount 
made available to carry out this section for such fiscal 
year exceeds the amount appropriated to carry out 
this section (as in effect before the date of enactment 
of the Restoring Hope for Mental Health and Well- 
Being Act of 2022) for fiscal year 2022.’’. 
CHAPTER 2—HELPING ENABLE ACCESS TO 
LIFESAVING SERVICES 
SEC. 1311. REAUTHORIZATION AND PROVISION OF CERTAIN 
PROGRAMS TO STRENGTHEN THE HEALTH 
CARE WORKFORCE. 
(a) MENTAL AND BEHAVIORAL HEALTH EDUCATION 
AND TRAINING GRANTS.—Section 756 of the Public Health 
Service Act (42 U.S.C. 294e–1) is amended— 
(1) in subsection (a)— 
(A) in paragraph (1), by inserting ‘‘(which 
may include master’s and doctoral level pro-
grams)’’ after ‘‘occupational therapy’’; and 
(B) in paragraph (4), by inserting before 
the period the following: ‘‘, including training to
3100 
† HR 2617 EAS2 
increase skills and capacity to meet the needs of 
children and adolescents who have experienced 
trauma’’; and 
(2) in subsection (f), by striking ‘‘For each of fis-
cal years 2019 through 2023’’ and inserting ‘‘For 
each of fiscal years 2023 through 2027’’. 
(b) TRAINING DEMONSTRATION PROGRAM.—Section 
760 of the Public Health Service Act (42 U.S.C. 294k) is 
amended— 
(1) by striking ‘‘mental and substance use dis-
orders’’ each place it appears and inserting ‘‘mental 
health and substance use disorder’’; 
(2) in subsection (a)(2)— 
(A) by inserting ‘‘(including for individuals 
completing clinical training requirements for li-
censure)’’ after ‘‘training’’; 
(B) by inserting ‘‘counselors, nurses,’’ after 
‘‘psychologists,’’; and 
(C) by striking the semicolon and inserting 
‘‘, including such settings that serve pediatric 
populations;’’; 
(3) in subsection (a)(3)(A)— 
(A) by striking ‘‘disorder’’ (as inserted by 
paragraph (1)) and inserting ‘‘disorders’’; and
3101 
† HR 2617 EAS2 
(B) by inserting ‘‘or pediatric populations’’ 
after ‘‘addiction’’; 
(4) in subsection (b)(2)(A), by inserting ‘‘(in-
cluding such settings that serve pediatric popu-
lations)’’ after ‘‘settings’’; 
(5) in subsection (c)(2)(F)— 
(A) by inserting ‘‘counselors, nurses,’’ after 
‘‘psychologists’’; and 
(B) by striking the period and inserting ‘‘, 
including such entities that serve pediatric popu-
lations.’’; 
(6) in subsection (d)(1)(A)— 
(A) by inserting ‘‘health service psycholo-
gists, nurses’’ after ‘‘fellows,’’; and 
(B) by inserting ‘‘counselors,’’ after ‘‘physi-
cian assistants’’; 
(7) in subsection (d)(1)(B)— 
(A) by inserting ‘‘, which may include such 
settings that serve pediatric populations’’ after 
‘‘settings’’; 
(B) by inserting ‘‘health’’ after ‘‘mental’’; 
(8) in subsection (d)(2)(C), inserting ‘‘(which 
may include trauma-informed care, as appropriate)’’ 
after ‘‘care’’;
3102 
† HR 2617 EAS2 
(9) in subsection (g), by striking ‘‘$10,000,000 
for each of fiscal years 2018 through 2022’’ and in-
serting ‘‘, and $31,700,000 for each of fiscal years 
2023 through 2027’’; and 
(10) in subsection (f)(2)(B), by striking ‘‘dis-
order’’ (as inserted by paragraph (1)) and inserting 
‘‘disorders’’. 
SEC. 1312. REAUTHORIZATION OF MINORITY FELLOWSHIP 
PROGRAM. 
Section 597(c) of the Public Health Service Act (42 
U.S.C. 290ll(c)) is amended by striking ‘‘$12,669,000 for 
each of fiscal years 2018 through 2022’’ and inserting 
‘‘$25,000,000 for each of fiscal years 2023 through 2027’’. 
CHAPTER 3—ELIMINATING THE OPT-OUT 
FOR 
NONFEDERAL 
GOVERNMENTAL 
HEALTH PLANS 
SEC. 1321. ELIMINATING THE OPT-OUT FOR NONFEDERAL 
GOVERNMENTAL HEALTH PLANS. 
Section 2722(a)(2) of the Public Health Service Act 
(42 U.S.C. 300gg–21(a)(2)) is amended by adding at the 
end the following new subparagraph: 
‘‘(F) SUNSET OF ELECTION OPTION.— 
‘‘(i) IN
GENERAL.—Notwithstanding 
the preceding provisions of this para-
graph—
3103 
† HR 2617 EAS2 
‘‘(I) no election described in sub-
paragraph (A) with respect to section 
2726 may be made on or after the date 
of the enactment of this subparagraph; 
and 
‘‘(II) except as provided in clause 
(ii), no such election with respect to 
section 2726 expiring on or after the 
date that is 180 days after the date of 
such enactment may be renewed. 
‘‘(ii) EXCEPTION
FOR
CERTAIN
COL-
LECTIVELY
BARGAINED
PLANS.—Notwith-
standing clause (i)(II), a plan described in 
subparagraph (B)(ii) that is subject to mul-
tiple agreements described in such subpara-
graph of varying lengths and that has an 
election described in subparagraph (A) with 
respect to section 2726 in effect as of the 
date of the enactment of this subparagraph 
that expires on or after the date that is 180 
days after the date of such enactment may 
extend such election until the date on which 
the term of the last such agreement ex-
pires.’’.
3104 
† HR 2617 EAS2 
CHAPTER 4—MENTAL HEALTH AND SUB-
STANCE USE DISORDER PARITY IM-
PLEMENTATION 
SEC. 1331. GRANTS TO SUPPORT MENTAL HEALTH AND SUB-
STANCE USE DISORDER PARITY IMPLEMEN-
TATION. 
(a) IN GENERAL.—Section 2794(c) of the Public 
Health Service Act (42 U.S.C. 300gg–94(c)) (as added by 
section 1003 of the Patient Protection and Affordable Care 
Act (Public Law 111–148)) is amended by adding at the 
end the following: 
‘‘(3) PARITY IMPLEMENTATION.— 
‘‘(A) IN GENERAL.—Beginning during the 
first fiscal year that begins after the date of en-
actment of this paragraph, the Secretary shall, 
out of funds made available pursuant to sub-
paragraph (C), award grants to eligible States to 
enforce and ensure compliance with the mental 
health and substance use disorder parity provi-
sions of section 2726. 
‘‘(B) ELIGIBLE STATE.—A State shall be el-
igible for a grant awarded under this paragraph 
only if such State— 
‘‘(i) submits to the Secretary an appli-
cation for such grant at such time, in such
3105 
† HR 2617 EAS2 
manner, and containing such information 
as specified by the Secretary; and 
‘‘(ii) agrees to request and review from 
health insurance issuers offering group or 
individual health insurance coverage the 
comparative analyses and other information 
required of such health insurance issuers 
under subsection (a)(8)(A) of section 2726 
relating to the design and application of 
nonquantitative treatment limitations im-
posed on mental health or substance use dis-
order benefits. 
‘‘(C) 
AUTHORIZATION
OF
APPROPRIA-
TIONS.—There are authorized to be appropriated 
$10,000,000 for each of the first five fiscal years 
beginning after the date of the enactment of this 
paragraph, to remain available until expended, 
for purposes of awarding grants under subpara-
graph (A).’’. 
(b) TECHNICAL AMENDMENT.—Section 2794 of the 
Public Health Service Act (42 U.S.C. 300gg–95), as added 
by section 6603 of the Patient Protection and Affordable 
Care Act (Public Law 111–148) is redesignated as section 
2795.
3106 
† HR 2617 EAS2 
Subtitle D—Children and Youth 
CHAPTER 1—SUPPORTING CHILDREN’S 
MENTAL HEALTH CARE ACCESS 
SEC. 1401. TECHNICAL ASSISTANCE FOR SCHOOL-BASED 
HEALTH CENTERS. 
Section 399Z–1 of the Public Health Service Act (42 
U.S.C. 280h–5) is amended— 
(1) by redesignating subsection (l) as subsection 
(m); and 
(2) by inserting after subsection (k) the fol-
lowing: 
‘‘(l) TECHNICAL ASSISTANCE.—The Secretary shall 
provide technical assistance by grants or contracts awarded 
to private, nonprofit entities with demonstrated expertise 
related to school-based health centers. Such technical assist-
ance, taking into account local and regional differences 
among school based health centers, shall support such enti-
ties in providing services described in subsection (a)(1) pur-
suant to this section, including mental health and substance 
use disorder services, and may include technical assistance 
relating to program operations and support for the imple-
mentation of evidence-based or evidence-informed best prac-
tices related to the provision of high quality health care 
services to children and adolescents.’’.
3107 
† HR 2617 EAS2 
SEC. 1402. INFANT AND EARLY CHILDHOOD MENTAL 
HEALTH PROMOTION, INTERVENTION, AND 
TREATMENT. 
Section 399Z–2 of the Public Health Service Act (42 
U.S.C. 280h–6) is amended— 
(1) by redesignating subsection (f) as subsection 
(g); 
(2) by inserting after subsection (e) the following: 
‘‘(f) TECHNICAL ASSISTANCE.—The Secretary may, 
directly or by awarding grants or contracts to public and 
private nonprofit entities, provide training and technical 
assistance to eligible entities to carry out activities de-
scribed in subsection (d).’’; and 
(3) in subsection (g) (as redesignated by para-
graph (1)), by striking ‘‘$20,000,000 for the period of 
fiscal years 2018 through 2022’’ and inserting 
‘‘$50,000,000 for the period of fiscal years 2023 
through 2027’’. 
SEC. 1403. CO-OCCURRING CHRONIC CONDITIONS AND 
MENTAL HEALTH IN YOUTH STUDY. 
Not later than 12 months after the date of enactment 
of this Act, the Secretary of Health and Human Services 
shall— 
(1) complete a study on the rates of suicidal be-
haviors among children and adolescents with chronic
3108 
† HR 2617 EAS2 
illnesses, including substance use disorders, auto-
immune disorders, and heritable blood disorders; and 
(2) submit a report to the Congress on the results 
of such study, including recommendations for early 
intervention services for such children and adolescents 
at risk of suicide, the dissemination of best practices 
to support the emotional and mental health needs of 
youth, and strategies to lower the rates of suicidal be-
haviors in children and adolescents described in para-
graph (1) to reduce any demographic disparities in 
such rates. 
SEC. 1404. BEST PRACTICES FOR BEHAVIORAL AND MENTAL 
HEALTH INTERVENTION TEAMS. 
The Public Health Service Act is amended by inserting 
after section 520H of such Act, as added by section 1151 
of this Act, the following new section: 
‘‘SEC. 520H–1. BEST PRACTICES FOR BEHAVIORAL AND MEN-
TAL HEALTH INTERVENTION TEAMS. 
‘‘(a) IN GENERAL.—The Secretary, acting through the 
Assistant Secretary for Mental Health and Substance Use, 
and in consultation with the Secretary of Education, shall 
submit to the Health Education, Labor, and Pensions Com-
mittee of the Senate and the Energy and Commerce Com-
mittee of the House of Representatives a report that identi-
fies best practices related to using behavioral and mental
3109 
† HR 2617 EAS2 
health intervention teams, which may be used to assist ele-
mentary schools, secondary schools, and institutions of 
higher education interested in voluntarily establishing and 
using such teams to support students exhibiting behaviors 
interfering with learning at school or who are at risk of 
harm to self or others. 
‘‘(b) ELEMENTS.—The report under subsection (a) 
shall assess evidence supporting such best practices and, as 
appropriate, include consideration of the following: 
‘‘(1) How behavioral and mental health interven-
tion teams might operate effectively from an evidence- 
based, objective perspective while protecting the con-
stitutional and civil rights and privacy of individ-
uals. 
‘‘(2) The use of behavioral and mental health 
intervention teams— 
‘‘(A) to identify and support students exhib-
iting behaviors interfering with learning or pos-
ing a risk of harm to self or others; and 
‘‘(B) to implement evidence-based interven-
tions to meet the behavioral and mental health 
needs of such students. 
‘‘(3) How behavioral and mental health interven-
tion teams can—
3110 
† HR 2617 EAS2 
‘‘(A) access evidence-based professional de-
velopment to support students described in para-
graph (2)(A); and 
‘‘(B) ensure that such teams— 
‘‘(i) are composed of trained, diverse 
stakeholders with expertise in child and 
youth development, behavioral and mental 
health, and disability; and 
‘‘(ii) use cross validation by a wide- 
range of individual perspectives on the 
team. 
‘‘(4) How behavioral and mental health interven-
tion teams can help mitigate inappropriate referral to 
mental health services or law enforcement by imple-
menting evidence-based interventions that meet stu-
dent needs. 
‘‘(c) CONSULTATION.—In carrying out subsection (a), 
the Secretary shall consult with— 
‘‘(1) the Secretary of Education; 
‘‘(2) the Director of the National Threat Assess-
ment Center of the United States Secret Service; 
‘‘(3) the Attorney General; 
‘‘(4) teachers (which shall include special edu-
cation teachers), principals and other school leaders, 
school board members, behavioral and mental health
3111 
† HR 2617 EAS2 
professionals (including school-based mental health 
professionals), and parents of students; 
‘‘(5) local law enforcement agencies and campus 
law enforcement administrators; 
‘‘(6) privacy, disability, and civil rights experts; 
and 
‘‘(7) other education and mental health profes-
sionals as the Secretary deems appropriate. 
‘‘(d) PUBLICATION.—The Secretary shall publish the 
report under subsection (a) in an accessible format on the 
internet website of the Department of Health and Human 
Services. 
‘‘(e) DEFINITIONS.—In this section: 
‘‘(1) The term ‘behavioral and mental health 
intervention team’ means a multidisciplinary team of 
trained individuals who— 
‘‘(A) are trained to identify and assess the 
behavioral health needs of children and youth 
and who are responsible for identifying, sup-
porting, and connecting students exhibiting be-
haviors interfering with learning at school, or 
who are at risk of harm to self or others, with 
appropriate behavioral health services; and 
‘‘(B) develop and facilitate implementation 
of evidence-based interventions to—
3112 
† HR 2617 EAS2 
‘‘(i) mitigate the threat of harm to self 
or others posed by a student described in 
subparagraph (A); 
‘‘(ii) meet the mental and behavioral 
health needs of such students; and 
‘‘(iii) support positive, safe, and sup-
portive learning environments. 
‘‘(2) The terms ‘elementary school’, ‘parent’, and 
‘secondary school’ have the meanings given to such 
terms in section 8101 of the Elementary and Sec-
ondary Education Act of 1965. 
‘‘(3) The term ‘institution of higher education’ 
has the meaning given to such term in section 102 of 
the Higher Education Act of 1965.’’. 
CHAPTER 2—CONTINUING SYSTEMS OF 
CARE FOR CHILDREN 
SEC. 1411. COMPREHENSIVE COMMUNITY MENTAL HEALTH 
SERVICES FOR CHILDREN WITH SERIOUS 
EMOTIONAL DISTURBANCES. 
(a) DEFINITION.—Section 565(d)(2)(B) of the Public 
Health Service Act (42 U.S.C. 290ff–4(d)(2)(B)) is amend-
ed by striking ‘‘may be)’’ and inserting ‘‘may be), kinship 
caregivers of the child,’’.
3113 
† HR 2617 EAS2 
(b) AUTHORIZATION
OF
APPROPRIATIONS.—Para-
graph (1) of section 565(f) of the Public Health Service Act 
(42 U.S.C. 290ff–4(f)) is amended— 
(1) by moving the margin of such paragraph 2 
ems to the right; and 
(2) by striking ‘‘$119,026,000 for each of fiscal 
years 
2018 
through 
2022’’ 
and 
inserting 
‘‘$125,000,000 for each of fiscal years 2023 through 
2027’’. 
SEC. 1412. SUBSTANCE USE DISORDER TREATMENT AND 
EARLY INTERVENTION SERVICES FOR CHIL-
DREN AND ADOLESCENTS. 
Section 514 of the Public Health Service Act (42 
U.S.C. 290bb–7) is amended— 
(1) in subsection (a), by striking ‘‘Indian tribes 
or tribal organizations’’ and inserting ‘‘Indian Tribes 
or Tribal organizations’’; and 
(2) in subsection (f), by striking ‘‘2018 through 
2022’’ and inserting ‘‘2023 through 2027’’.
3114 
† HR 2617 EAS2 
CHAPTER 3—GARRETT LEE SMITH 
MEMORIAL REAUTHORIZATION 
SEC. 1421. SUICIDE PREVENTION TECHNICAL ASSISTANCE 
CENTER. 
(a) TECHNICAL AMENDMENT.—Section 520C of the 
Public Health Service Act (42 U.S.C. 290bb–34) is amend-
ed— 
(1) by striking ‘‘tribes’’ and inserting ‘‘Tribes’’; 
and 
(2) by striking ‘‘tribal’’ each place it appears 
and inserting ‘‘Tribal’’. 
(b) COLLABORATION.—Section 520C(a) of the Public 
Health Service Act (42 U.S.C. 290bb–34(a)) is amended— 
(1) by striking ‘‘The Secretary’’ and inserting 
the following: 
‘‘(1) IN GENERAL.—The Secretary’’; and 
(2) by adding at the end the following: 
‘‘(2) COLLABORATION.—In carrying out this sub-
section, as applicable with respect to assistance to en-
tities serving members of the Armed Forces and vet-
erans, the Secretary shall, as appropriate, collaborate 
with the Secretary of Defense and the Secretary of 
Veterans Affairs.’’. 
(c) AUTHORIZATION
OF APPROPRIATIONS.—Section 
520C(c) of the Public Health Service Act (42 U.S.C. 290bb–
3115 
† HR 2617 EAS2 
34(c)) is amended by striking ‘‘$5,988,000 for each of fiscal 
years 2018 through 2022’’ and inserting ‘‘$9,000,000 for 
each of fiscal years 2023 through 2027’’. 
(d) ANNUAL REPORT.—Section 520C(d) of the Public 
Health Service Act (42 U.S.C. 290bb–34(d)) is amended by 
striking ‘‘Not later than 2 years after the date of enactment 
of this subsection, the Secretary shall submit to Congress’’ 
and inserting ‘‘Not later than 2 years after the date of the 
enactment of the Restoring Hope for Mental Health and 
Well-Being Act of 2022, the Secretary shall submit to the 
Committee on Health, Education, Labor, and Pensions of 
the Senate and the Committee on Energy and Commerce 
of the House of Representatives’’. 
SEC. 1422. YOUTH SUICIDE EARLY INTERVENTION AND PRE-
VENTION STRATEGIES. 
Section 520E of the Public Health Service Act (42 
U.S.C. 290bb–36) is amended— 
(1) by striking ‘‘tribe’’ and inserting ‘‘Tribe’’; 
(2) by striking ‘‘tribal’’ each place it appears 
and inserting ‘‘Tribal’’; 
(3) in subsection (a)(1), by inserting ‘‘pediatric 
health programs,’’ after ‘‘foster care systems,’’; 
(4) by amending subsection (b)(1)(B) to read as 
follows:
3117 
† HR 2617 EAS2 
means commonly used in suicide, if applicable, with-
in the household.’’; 
(6) in subsection (d)— 
(A) in the heading, by striking ‘‘DIRECT 
SERVICES’’ and inserting ‘‘SUICIDE PREVENTION 
ACTIVITIES’’; and 
(B) by striking ‘‘direct services, of which 
not less than 5 percent shall be used for activities 
authorized under subsection (a)(3)’’ and insert-
ing ‘‘suicide prevention activities’’; 
(7) in subsection (e)(3)(A), by inserting ‘‘and the 
Department of Education, as appropriate’’ after 
‘‘agencies and suicide working groups’’; 
(8) in subsection (g)— 
(A) in paragraph (1), by striking ‘‘18’’ and 
inserting ‘‘24’’; and 
(B) in paragraph (2), by striking ‘‘2 years 
after the date of enactment of Helping Families 
in Mental Health Crisis Reform Act of 2016’’ 
and inserting ‘‘December 31, 2025’’; 
(9) in subsection (l)(4), by striking ‘‘between 10 
and 24 years of age’’ and inserting ‘‘up to 24 years 
of age’’; and 
(10) in subsection (m), by striking ‘‘$30,000,000 
for each of fiscal years 2018 through 2022’’ and in-
3118 
† HR 2617 EAS2 
serting ‘‘$40,000,000 for each of fiscal years 2023 
through 2027’’. 
SEC. 1423. MENTAL HEALTH AND SUBSTANCE USE DIS-
ORDER SERVICES FOR STUDENTS IN HIGHER 
EDUCATION. 
Section 520E–2 of the Public Health Service Act (42 
U.S.C. 290bb–36b) is amended— 
(1) in the heading, by striking ‘‘ON CAMPUS’’ 
and inserting ‘‘FOR STUDENTS IN HIGHER EDU-
CATION’’; 
(2) in subsection (b)— 
(A) in paragraph (1), by striking ‘‘mental 
and substance use disorders’’ and inserting 
‘‘mental health and substance use disorders and 
promote resiliency’’; 
(B) in paragraph (4), by striking ‘‘mental 
and substance use disorder services.’’ and insert-
ing ‘‘mental health and substance use disorder 
resources and services.’’; 
(C) in paragraph (5), by striking ‘‘mental 
and substance use’’ and inserting ‘‘mental health 
and substance use’’; 
(D) in paragraph (6), by striking ‘‘staff to 
respond effectively to students with mental and 
substance use disorders.’’ and inserting ‘‘staff to
3119 
† HR 2617 EAS2 
recognize and respond effectively and appro-
priately to students experiencing mental health 
and substance use disorders.’’; 
(E) in paragraph (7), by striking ‘‘mental 
and substance use’’ and inserting ‘‘mental health 
and substance use’’; 
(F) in paragraph (8), by striking ‘‘mental 
and substance use’’ and inserting ‘‘mental health 
and substance use.’’; 
(G) in paragraph (9), by striking ‘‘regard-
ing improving the behavioral health of students 
through clinical services, outreach, prevention, 
or’’ and inserting ‘‘to improve the behavioral 
health of students through clinical services, out-
reach, prevention, promotion of mental health, 
or’’; 
(H) in paragraph (10), by striking ‘‘mental 
and behavioral disorders,’’ and inserting ‘‘mental 
and behavioral health disorders,’’; and 
(I) in paragraph (12), by striking ‘‘best 
practices.’’ and inserting ‘‘best practices, and 
trauma-informed practices.’’; 
(3) in subsection (d)—
3120 
† HR 2617 EAS2 
(A) in paragraph (1), by striking ‘‘mental 
and substance use’’ and inserting ‘‘mental health 
and substance use’’; and 
(B) in paragraph (3), by striking ‘‘pro-
moting access to services,’’ and inserting ‘‘pro-
moting mental health and access to services,’’ 
(4) in subsection (f)— 
(A) in the matter preceding paragraph (1), 
by striking ‘‘the Congress’’ and inserting ‘‘the 
Committee on Energy and Commerce of the 
House of Representatives and the Committee on 
Health, Education, Labor, and Pensions of the 
Senate’’; 
(B) in paragraph (2), by striking ‘‘includ-
ing efforts’’ and inserting ‘‘including through 
prevention, early detection, early intervention, 
and efforts’’; and 
(C) by adding at the end the following: 
‘‘(3) An assessment of the mental health and sub-
stance use disorder needs of the populations served by 
recipients of grants under this section.’’; and 
(5) in subsection (i), by striking ‘‘2018 through 
2022’’ and inserting ‘‘2023 through 2027’’;
3121 
† HR 2617 EAS2 
SEC. 1424. MENTAL AND BEHAVIORAL HEALTH OUTREACH 
AND EDUCATION AT INSTITUTIONS OF HIGH-
ER EDUCATION. 
Section 549 of the Public Health Service Act (42 
U.S.C. 290ee–4) is amended— 
(1) in the heading, by striking ‘‘ON COLLEGE 
CAMPUSES’’ and inserting ‘‘AT INSTITUTIONS OF 
HIGHER EDUCATION’’; 
(2) in subsection (c)(2), by inserting ‘‘, including 
minority-serving institutions as described in section 
371(a) of the Higher Education Act of 1965 (20 
U.S.C. 1067q) and community colleges’’ after ‘‘higher 
education’’; and 
(3) in subsection (f), by striking ‘‘2018 through 
2022’’ and inserting ‘‘2023 through 2027’’. 
CHAPTER 4—MEDIA AND MENTAL HEALTH 
SEC. 1431. STUDY ON THE EFFECTS OF SMARTPHONE AND 
SOCIAL MEDIA USE ON ADOLESCENTS. 
(a) IN GENERAL.—Not later than 1 year after the date 
of enactment of this Act, the Secretary of Health and 
Human Services may conduct or support research on— 
(1) smartphone and social media use by adoles-
cents; and 
(2) the effects of such use on— 
(A) emotional, behavioral, and physical 
health and development; and
3122 
† HR 2617 EAS2 
(B) any disparities in the mental health 
outcomes of rural, minority, and other under-
served populations. 
(b) REPORT.—Not later than 5 years after the date 
of enactment of this Act, the Secretary of Health and 
Human Services shall submit to the Congress, and make 
publicly available, a report on the findings of research 
under this section. 
SEC. 1432. RESEARCH ON THE HEALTH AND DEVELOPMENT 
EFFECTS OF MEDIA AND RELATED TECH-
NOLOGY ON INFANTS, CHILDREN, AND ADO-
LESCENTS. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services (in this section referred to as the ‘‘Sec-
retary’’) shall, as appropriate, conduct or support research 
related to the health and developmental effects, including 
long-term effects, of media and related technology use on 
infants, children, and adolescents, which may include the 
effects of exposure to, and use of, media and related tech-
nology, such as social media, applications, websites, tele-
vision, motion pictures, artificial intelligence, mobile de-
vices, computers, video games, virtual and augmented re-
ality, and other content, networks, or platforms dissemi-
nated through the internet, broadcasted, or other media 
technologies, as applicable.
3123 
† HR 2617 EAS2 
(b) ACTIVITIES.—In carrying out subsection (a), the 
Secretary, acting through the Director of the National Insti-
tutes of Health, shall, as appropriate, develop a research 
agenda to assess the effects of media and related technologies 
on infants, children, and adolescents, which may include 
consideration of the following, as appropriate: 
(1) The cognitive development of infants, chil-
dren, and adolescents, which may include effects re-
lated to language development, learning abilities, and 
other areas of cognitive development. 
(2) The physical health of infants, children, and 
adolescents, which may include effects related to diet, 
exercise, sleeping and eating routines, and other areas 
of physical development. 
(3) The mental health of infants, children, and 
adolescents, which may include effects related to self- 
awareness, social awareness, relationship skills, deci-
sion-making, violence, bullying, privacy, mental dis-
orders, and other areas related to mental health. 
(c) CONSULTATION.—In developing the research agen-
da under subsection (b), the Secretary may consult with ap-
propriate national research institutes, academies, and cen-
ters, relevant consortia, and non-Federal experts, as appro-
priate. The Secretary may utilize scientific workshops, 
symposia, and other activities to assess current knowledge
3124 
† HR 2617 EAS2 
and identify relevant research opportunities and gaps in 
this area. 
(d) REPORT TO CONGRESS.—Not later than 2 years 
after the date of enactment of this Act, the Director of the 
National Institutes of Health shall submit to the Committee 
on Energy and Commerce of the House of Representatives 
and the Committee on Health, Education, Labor, and Pen-
sions of the Senate a report— 
(1) on the progress made in improving data and 
expanding research on the health and developmental 
effects of media and related technology on infants, 
children, and adolescents in accordance with this sec-
tion; and 
(2) that summarizes the grants and research 
funded under this section for each of the years covered 
by the report. 
Subtitle E—Miscellaneous 
Provisions 
SEC. 1501. LIMITATIONS ON AUTHORITY. 
In carrying out any program of the Substance Abuse 
and Mental Health Services Administration whose statu-
tory authorization is enacted or amended by this title, the 
Secretary of Health and Human Services shall not allocate 
funding, or require award recipients to prioritize, dedicate, 
or allocate funding, without consideration of the incidence,
3125 
† HR 2617 EAS2 
prevalence, or determinants of mental health or substance 
use issues, unless such allocation or requirement is con-
sistent with statute, regulation, or other Federal law. 
TITLE II—PREPARING FOR AND 
RESPONDING TO EXISTING VI-
RUSES, 
EMERGING 
NEW 
THREATS, AND PANDEMICS 
SEC. 2001. SHORT TITLE. 
This title may be cited as the ‘‘Prepare for and Re-
spond to Existing Viruses, Emerging New Threats, and 
Pandemics Act’’ or the ‘‘PREVENT Pandemics Act’’. 
Subtitle A—Strengthening Federal 
and State Preparedness 
CHAPTER 1—FEDERAL LEADERSHIP AND 
ACCOUNTABILITY 
SEC. 2101. APPOINTMENT AND AUTHORITY OF THE DIREC-
TOR OF THE CENTERS FOR DISEASE CON-
TROL AND PREVENTION. 
(a) IN GENERAL.—Part A of title III of the Public 
Health Service Act (42 U.S.C. 241 et seq.) is amended by 
inserting after section 304 the following:
3126 
† HR 2617 EAS2 
‘‘SEC. 305. APPOINTMENT AND AUTHORITY OF THE DIREC-
TOR OF THE CENTERS FOR DISEASE CON-
TROL AND PREVENTION. 
‘‘(a) IN GENERAL.—The Centers for Disease Control 
and Prevention (referred to in this section as the ‘CDC’) 
shall be headed by the Director of the Centers for Disease 
Control and Prevention (referred to in this section as the 
‘Director’), who shall be appointed by the President, by and 
with the advice and consent of the Senate. Such individual 
shall also serve as the Administrator of the Agency for Toxic 
Substances and Disease Registry consistent with section 
104(i) of the Comprehensive Environmental Response, 
Compensation, and Liability Act. The Director shall per-
form functions provided for in subsection (b) and such other 
functions as the Secretary may prescribe. 
‘‘(b) FUNCTIONS.—The Secretary, acting through the 
Director, shall— 
‘‘(1) implement and exercise applicable authori-
ties and responsibilities provided for in this Act or 
other applicable law related to the investigation, de-
tection, identification, prevention, or control of dis-
eases or conditions to preserve and improve public 
health domestically and globally and address injuries 
and occupational and environmental hazards, as ap-
propriate;
3127 
† HR 2617 EAS2 
‘‘(2) be responsible for the overall direction of the 
CDC and for the establishment and implementation of 
policies related to the management and operation of 
programs and activities within the CDC; 
‘‘(3) coordinate and oversee the operation of cen-
ters, institutes, and offices within the CDC; 
‘‘(4) support, in consultation with the heads of 
such centers, institutes, and offices, program coordi-
nation across such centers, institutes, and offices, in-
cluding through priority setting reviews and the de-
velopment of strategic plans, to reduce unnecessary 
duplication and encourage collaboration between pro-
grams; 
‘‘(5) oversee the development, implementation, 
and updating of the strategic plan established pursu-
ant to subsection (c); 
‘‘(6) ensure that appropriate strategic planning, 
including the use of performance metrics, is conducted 
by such centers, institutes, and offices to facilitate 
and improve CDC programs and activities; 
‘‘(7) communicate, including through convening 
annual meetings, with public and private entities re-
garding relevant public health programs and activi-
ties, and, as applicable, the strategic plan established 
pursuant to subsection (c).
3128 
† HR 2617 EAS2 
‘‘(c) STRATEGIC PLAN.— 
‘‘(1) IN GENERAL.—Not later than 1 year after 
the date of enactment of the PREVENT Pandemics 
Act, and at least every 4 years thereafter, the Director 
shall develop and submit to the Committee on Health, 
Education, Labor, and Pensions and the Committee 
on Appropriations of the Senate and the Committee 
on Energy and Commerce and the Committee on Ap-
propriations of the House of Representatives, and post 
on the website of the CDC, a coordinated strategy to 
provide strategic direction and facilitate collaboration 
across the centers, institutes, and offices within the 
CDC. Such strategy shall be known as the ‘CDC Stra-
tegic Plan’. 
‘‘(2) REQUIREMENTS.—The CDC Strategic Plan 
shall— 
‘‘(A) identify strategic priorities and objec-
tives related to— 
‘‘(i) preventing, reducing, and elimi-
nating the spread of communicable and 
noncommunicable diseases or conditions, 
and addressing injuries, and occupational 
and environmental hazards; 
‘‘(ii) supporting the efforts of State, 
local, and Tribal health departments to pre-
3129 
† HR 2617 EAS2 
vent and reduce the prevalence of the dis-
eases or conditions under clause (i); 
‘‘(iii) containing, mitigating, and end-
ing disease outbreaks; 
‘‘(iv) enhancing global and domestic 
public health capacity, capabilities, and 
preparedness, including public health data, 
surveillance, workforce, and laboratory ca-
pacity and safety; and 
‘‘(v) other priorities, as established by 
the Director; 
‘‘(B) describe the capacity and capabilities 
necessary to achieve the priorities and objectives 
under subparagraph (A), and progress towards 
achieving such capacity and capabilities, as ap-
propriate; and 
‘‘(C) include a description of how the CDC 
Strategic Plan incorporates— 
‘‘(i) strategic communications; 
‘‘(ii) partnerships with private sector 
entities, and State, local, and Tribal health 
departments, and other public sector enti-
ties, as appropriate; and 
‘‘(iii) coordination with other agencies 
and offices of the Department of Health and
3130 
† HR 2617 EAS2 
Human Services and other Federal depart-
ments and agencies, as appropriate. 
‘‘(3) USE OF PLANS.—Strategic plans developed 
and updated by the centers, institutes, and offices of 
the CDC shall be prepared regularly and in such a 
manner that such plans will be informed by the CDC 
Strategic Plan developed and updated under this sub-
section. 
‘‘(d) APPEARANCES BEFORE CONGRESS.— 
‘‘(1) IN GENERAL.—Each fiscal year, the Direc-
tor shall appear before the Committee on Health, 
Education, Labor, and Pensions of the Senate and the 
Committee on Energy and Commerce of the House of 
Representatives at hearings on topics such as— 
‘‘(A) support for State, local, and Tribal 
public health preparedness and responses to any 
recent or ongoing public health emergency, in-
cluding— 
‘‘(i) any objectives, activities, or initia-
tives that have been carried out, or are 
planned, by the Director to prepare for, or 
respond to, the public health emergency, in-
cluding relevant strategic communications 
or partnerships and any gaps or challenges
3131 
† HR 2617 EAS2 
identified in such objectives, activities, or 
initiatives; 
‘‘(ii) any objectives and planned ac-
tivities for the upcoming fiscal year to ad-
dress gaps in, or otherwise improve, State, 
local, and Tribal public health prepared-
ness; and 
‘‘(iii) other potential all-hazard threats 
that the Director is preparing to address; 
‘‘(B) activities related to public health and 
functions of the Director described in subsection 
(b); and 
‘‘(C) updates on other relevant activities 
supported or conducted by the CDC, or in col-
laboration or coordination with the heads of 
other Federal departments, agencies, or stake-
holders, as appropriate. 
‘‘(2) CLARIFICATIONS.— 
‘‘(A) WAIVER
AUTHORITY.—The Chair of 
the Committee on Health, Education, Labor, and 
Pensions of the Senate or the Chair of the Com-
mittee on Energy and Commerce of the House of 
Representatives may waive the requirements of 
paragraph (1) for the applicable fiscal year with 
respect to the applicable Committee.
3132 
† HR 2617 EAS2 
‘‘(B) SCOPE OF REQUIREMENTS.—The re-
quirements of this subsection shall not be con-
strued to impact the appearance of other Federal 
officials or the Director at hearings of either 
Committee described in paragraph (1) at other 
times and for purposes other than the times and 
purposes described in paragraph (1). 
‘‘(3) CLOSED
HEARINGS.—Information that is 
not appropriate for disclosure during an open hear-
ing under paragraph (1) in order to protect national 
security may instead be discussed in a closed hearing 
that immediately follows the open hearing. 
‘‘(e) OTHER TRANSACTIONS.— 
‘‘(1) IN GENERAL.—In carrying out activities of 
the Centers for Disease Control and Prevention, the 
Director may enter into transactions other than a 
contract, grant, or cooperative agreement for purposes 
of infectious disease research, biosurveillance, infec-
tious disease modeling, and public health prepared-
ness and response. 
‘‘(2) WRITTEN DETERMINATION.—With respect to 
a project that is expected to cost the Centers for Dis-
ease Control and Prevention more than $40,000,000, 
the Director may exercise the authority under para-
graph (1) only upon a written determination by the
3133 
† HR 2617 EAS2 
Assistant Secretary for Financial Resources of the De-
partment of Health and Human Services, that the use 
of such authority is essential to promoting the success 
of the project. The authority of the Assistant Sec-
retary for Financial Resources under this paragraph 
may not be delegated. 
‘‘(3) GUIDELINES.—The Director, in consulta-
tion with the Secretary, shall establish guidelines re-
garding the use of the authority under paragraph (1). 
Such guidelines shall include auditing requirements.’’. 
(b) EFFECTIVE DATE.—The first sentence of section 
305(a) of the Public Health Service Act, as added by sub-
section (a), shall take effect on January 20, 2025. 
SEC. 2102. ADVISORY COMMITTEE TO THE DIRECTOR OF 
THE CENTERS FOR DISEASE CONTROL AND 
PREVENTION. 
Title III of the Public Health Service Act (42 U.S.C. 
241 et seq.) is amended by inserting after section 305, as 
added by section 2101, the following: 
‘‘SEC. 305A. ADVISORY COMMITTEE TO THE DIRECTOR. 
‘‘(a) IN GENERAL.—Not later than 60 days after the 
date of the enactment of the PREVENT Pandemics Act, the 
Secretary, acting through the Director of the Centers for 
Disease Control and Prevention (referred to in this section 
as the ‘Director’), shall maintain or establish an advisory
3134 
† HR 2617 EAS2 
committee within the Centers for Disease Control and Pre-
vention to advise the Director on policy and strategies that 
enable the agency to fulfill its mission. 
‘‘(b) FUNCTIONS
AND
ACTIVITIES.—The Advisory 
Committee may— 
‘‘(1) make recommendations to the Director re-
garding ways to prioritize the activities of the agency 
in alignment with the CDC Strategic Plan required 
under section 305(c); 
‘‘(2) advise on ways to achieve or improve per-
formance metrics in relation to the CDC Strategic 
Plan, and other relevant metrics, as appropriate; 
‘‘(3) provide advice and recommendations on the 
development of the CDC Strategic Plan, and any sub-
sequent updates, as appropriate; 
‘‘(4) advise on grants, cooperative agreements, 
contracts, or other transactions, as applicable; 
‘‘(5) provide other advice to the Director, as re-
quested, to fulfill duties under sections 301 and 311; 
and 
‘‘(6) appoint subcommittees. 
‘‘(c) MEMBERSHIP.— 
‘‘(1) IN
GENERAL.—The Advisory Committee 
shall consist of not more than 15 non-Federal mem-
3135 
† HR 2617 EAS2 
bers, including the Chair, to be appointed by the Sec-
retary under paragraph (3). 
‘‘(2) EX
OFFICIO
MEMBERS.—Any ex officio 
members of the Advisory Council may consist of— 
‘‘(A) the Secretary; 
‘‘(B) the Assistant Secretary for Health; 
‘‘(C) the Director; and 
‘‘(D) such additional officers or employees 
of the United States as the Secretary determines 
necessary for the advisory committee to effec-
tively carry out its functions. 
‘‘(3) APPOINTED
MEMBERS.—Individuals shall 
be appointed to the Advisory Committee under para-
graph (1) as follows: 
‘‘(A) Twelve of the members shall be ap-
pointed by the Director from among the leading 
representatives of the health disciplines (includ-
ing public health, global health, health dispari-
ties, biomedical research, public health prepared-
ness, and other fields, as applicable) relevant to 
the activities of the agency or center, as applica-
ble. 
‘‘(B) Three of the members may be ap-
pointed by the Secretary from the general public 
and may include leaders in fields of innovation,
3136 
† HR 2617 EAS2 
public policy, public relations, law, economics, or 
management. 
‘‘(4) COMPENSATION.—Ex officio members of the 
Advisory Council who are officers or employees of the 
United States shall not receive any compensation for 
service on the advisory committee. The remaining 
members of the advisory committee may receive, for 
each day (including travel time) they are engaged in 
the performance of the functions of the advisory com-
mittee, compensation at rates not to exceed the daily 
equivalent to the annual rate of basic pay for level III 
of the Executive Schedule under section 5314 of title 
5, United States Code. 
‘‘(5) TERMS OF OFFICE.— 
‘‘(A) IN GENERAL.—The term of office of a 
member of the advisory committee appointed 
under paragraph (3) shall be 4 years, except that 
any member appointed to fill a vacancy for an 
unexpired term shall serve for the remainder of 
such term. The Secretary shall make appoint-
ments to the advisory committee in such a man-
ner as to ensure that the terms of the members 
not all expire in the same year. A member of the 
advisory committee may serve after the expira-
3137 
† HR 2617 EAS2 
tion of such member’s term until a successor has 
been appointed and taken office. 
‘‘(B) REAPPOINTMENTS.—A member who 
has been appointed to the advisory committee for 
a term of 4 years may not be reappointed to the 
advisory committee during the 2-year period be-
ginning on the date on which such 4-year term 
expired. 
‘‘(C) TIME
FOR
APPOINTMENT.—If a va-
cancy occurs in the advisory committee among 
the members appointed under paragraph (3), the 
Secretary shall make an appointment to fill such 
vacancy within 90 days from the date the va-
cancy occurs. 
‘‘(d) CHAIR.—The Secretary shall select a member of 
the advisory committee to serve as the Chair of the com-
mittee. The Secretary may so select an individual from 
among the appointed members. The term of office of the 
chair shall be 2 years. 
‘‘(e) MEETINGS.—The advisory committee shall meet 
at the call of the Chair or upon request of the Director, 
but in no event less than 2 times during each fiscal year. 
‘‘(f) EXECUTIVE SECRETARY AND STAFF.—The Direc-
tor shall designate a member of the staff of the agency to 
serve as the executive secretary of the advisory committee.
3138 
† HR 2617 EAS2 
The Director shall make available to the advisory committee 
such staff, information, and other assistance as it may re-
quire to carry out its functions. The Director shall provide 
orientation and training for new members of the advisory 
committee to provide for their effective participation in the 
functions of the advisory committee.’’. 
SEC. 2103. PUBLIC HEALTH AND MEDICAL PREPAREDNESS 
AND RESPONSE COORDINATION. 
(a) PUBLIC HEALTH EMERGENCY FUND.—Section 
319(b) of the Public Health Service Act (42 U.S.C. 247d(b)) 
is amended— 
(1) in paragraph (2)— 
(A) in subparagraph (E), by striking ‘‘and’’ 
at the end; 
(B) by redesignating subparagraph (F) as 
subparagraph (G); and 
(C) by inserting after subparagraph (E), 
the following: 
‘‘(F) support the initial deployment and 
distribution of contents of the Strategic National 
Stockpile, as appropriate; and’’; and 
(2) by amending paragraph (3)(A) to read as 
follows:
3139 
† HR 2617 EAS2 
‘‘(A) the expenditures made from the Public 
Health Emergency Fund in such fiscal year, in-
cluding— 
‘‘(i) the amount obligated; 
‘‘(ii) the recipient or recipients of such 
obligated funds; 
‘‘(iii) the specific response activities 
such obligated funds will support; and 
‘‘(iv) the declared or potential public 
health emergency for which such funds were 
obligated; and’’. 
(b) IMPROVING PUBLIC HEALTH AND MEDICAL PRE-
PAREDNESS AND RESPONSE COORDINATION.— 
(1) COORDINATION WITH FEDERAL AGENCIES.— 
Section 2801 of the Public Health Service Act (42 
U.S.C. 300hh) is amended by adding at the end the 
following: 
‘‘(c) COORDINATION WITH FEDERAL AGENCIES.—In 
leading the Federal public health and medical response to 
a declared or potential public health emergency, consistent 
with this section, the Secretary shall coordinate with, and 
may request support from, other Federal departments and 
agencies, as appropriate in order to carry out necessary ac-
tivities and leverage the expertise of such departments and 
agencies, which may include the provision of assistance at
3140 
† HR 2617 EAS2 
the direction of the Secretary related to supporting the pub-
lic health and medical response for States, localities, and 
Tribes.’’. 
(2) ASPR DUTIES.—Section 2811(b) of the Pub-
lic Health Service Act (42 U.S.C. 300hh–10(b)) is 
amended— 
(A) in paragraph (1), by inserting ‘‘and, 
consistent with the National Response Frame-
work and other applicable provisions of law, as-
sist the Secretary in carrying out the functions 
under section 2801’’ before the period; and 
(B) in paragraph (4)— 
(i) in subparagraph (E) by striking 
‘‘the actions necessary to overcome these ob-
stacles.’’ and inserting ‘‘recommend actions 
necessary to overcome these obstacles, such 
as— 
‘‘(i) improving coordination with rel-
evant Federal officials; 
‘‘(ii) partnering with other public or 
private entities to leverage capabilities 
maintained by such entities, as appropriate 
and consistent with this subsection; and 
‘‘(iii) coordinating efforts to support or 
establish new capabilities, as appropriate.’’;